Mogamulizumab induces long‐term immune restoration and reshapes tumour heterogeneity in Sézary syndrome *
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Dermatology"
DOI: 10.1111/bjd.21018
Abstract: Mogamulizumab, an anti‐CCR4 monoclonal antibody, has been shown to increase progression‐free survival in cutaneous T‐cell lymphoma. read more here.
Keywords: long term; immune restoration; induces long; mogamulizumab induces ... See more keywords
Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers.
Sign Up to like & getrecommendations! Published in 2021 at "Asian Pacific journal of allergy and immunology"
DOI: 10.12932/ap-250721-1197
Abstract: BACKGROUND Inactivated SARS-CoV-2 (CoronaVac®, Sinovac, or SV) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-Astra Zeneca, or AZ) vaccines have been administered to the health care workers (HCWs). OBJECTIVE To determine the short-term immune response after the SV… read more here.
Keywords: short term; immune response; term immune; sars cov ... See more keywords